Anavex Life Deferred Long Term Liab Over Time
| AVXL Stock | USD 8.38 0.08 0.96% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Anavex Life Performance and Anavex Life Correlation. Anavex |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Deferred Long Term Liab Analysis
Compare Anavex Life Sciences and related stocks such as Cassava Sciences, INmune Bio, and Biovie Inc Deferred Long Term Liab Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SAVA | 41.3 M | 41.3 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 33.7 M | 30.4 M | 30 M |
| BIVI | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| ANVS | 369.6 K | 369.6 K | 369.6 K | 369.6 K | 369.6 K | 369.6 K | 369.6 K | 369.6 K | 369.6 K | 369.6 K | 369.6 K | 369.6 K | 369.6 K | 332.6 K | 295.7 K |
| IOVA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 230 K | 230 K | 230 K | 230 K | 230 K | 264.5 K | 277.7 K |
| AXSM | 42.6 K | 42.6 K | 42.6 K | 42.6 K | 42.6 K | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| NVAX | 4.8 M | 4.8 M | 9.4 M | 11 M | 0.0 | 0.0 | 0.0 | 0.0 | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 2.2 M | 2.7 M |
| EXEL | 16.3 M | 16.3 M | 0.0 | 0.0 | 0.0 | 0.0 | 237.1 M | 238.5 M | 238.5 M | 238.5 M | 238.5 M | 238.5 M | 238.5 M | 274.3 M | 288 M |
| TGTX | 0.0 | 0.0 | 1.8 M | 1.7 M | 1.5 M | 1.4 M | 2 M | 2.4 M | 2.4 M | 762 K | 610 K | 457 K | 305 K | 274.5 K | 260.8 K |
| VKTX | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 31.2 K | 16.3 K | 270 K | 12 K | 128 K | 48 K | 76 K | 38 K | 34.2 K | 32.5 K |
| MDGL | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| BTAI | 461 K | 461 K | 461 K | 461 K | 461 K | 461 K | 461 K | 461 K | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.3 M | 2.7 M | 1.5 M |
| EYEN | 328.7 K | 328.7 K | 328.7 K | 328.7 K | 328.7 K | 328.7 K | 328.7 K | 328.7 K | 45.4 K | 45.4 K | 38.7 K | 38.7 K | 38.7 K | 34.8 K | 33.1 K |
| RNAZ | 224.2 K | 224.2 K | 224.2 K | 224.2 K | 224.2 K | 224.2 K | 224.2 K | 224.2 K | 224.2 K | 224.2 K | 224.2 K | 224.2 K | 224.2 K | 201.7 K | 179.3 K |
Anavex Life Sciences and related stocks such as Cassava Sciences, INmune Bio, and Biovie Inc Deferred Long Term Liab description
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.My Equities
My Current Equities and Potential Positions
| Anavex Life Sciences | AVXL |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | New York; U.S.A |
| Exchange | NASDAQ Exchange |
USD 8.38
Check out Anavex Life Performance and Anavex Life Correlation. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Anavex Life technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.